Whether you’re seeking to start a drug monitoring program or to supplement an existing program with additional testing, Quest Diagnostics offers urine and oral fluid drug testing to meet the needs of your health system and your healthcare providers.
We offer a broad test menu, advanced technologies, and extensive expertise that enable health systems to implement a drug monitoring program that can protect your providers and their patients.
Buprenorphine provider gap in Midwest and Mid-Atlantic
The number of approved providers of buprenorphine per opioid overdose death is lower than average in 11 states in the Midwest and Mid-Atlantic, according to an analysis by the health policy consulting group Avalere. Buprenorphine is used to treat opiate use disorder, and may be prescribed by nurse practitioners and…
Over 650 MDs, PhDs, genetic counselors, and toxicologists are available for results interpretation and consultation on all of our drug tests.
Dr. McClure is a Director of Medical Affairs for Quest Diagnostics, and a leading figure in the field of clinical drug monitoring.